Search PubMed⌕ Search

Biomedical subjects

T C Prager

Publications and source records attributed to T C Prager.

At least 19 recordsLinked to original sources

The Houston Vision Assessment Test (HVAT): an assessment of validity. The Cataract Outcome Study Group.

PURPOSE: Cataract surgery is one of the most successful procedures in medicine, and outcome is typically measured by a single factor - improvement in visual acuity. Health-related functional outcome testing, which quantifies the patient's self-reported perception of impairment, can be integrated with objective clinical findings. Based on the patient's self-assessed lifestyle impairment, the physician and patient together can make an informed decision on the treatment that is most likely to benefit the patient. METHOD: A functional outcome test (the Houston Vision Assessment Test - HVAT, copyrighted 1990, 1992) was evaluated in a cataract population of 149 patients from seven study centers. Test results were correlated with objective ophthalmic endpoints. The HVAT divides an estimated total impairment into subcomponents of Visual Impairment (correctable by cataract surgery) and non-visual Physical Impairments (co-morbidities not affected by cataract surgery). RESULTS: In this prospective study, the average Visual Impairment score improved by 19 points (65%) following cataract extraction (the mean HVAT Visual Impairment score was 29 points before surgery and 10 points at 5 months post-surgery, a change of 65%). Physical Impairment remained unchanged by surgery. Visual acuity was a poor predictor of Visual Impairment. CONCLUSIONS: The HVAT has 11 simple questions. It may be self-administered and is available on the Internet: http://www.DHAC.com. The physician may err if his decision in favor of cataract surgery is based only on visual acuity. The HVAT has the potential to guide the decision-making process between patient and physician.

Adult↗

Evaluation of methods for assessing visual function of infants.

PURPOSE: Commonly used behavioral and electrical testing methods for estimation of visual acuity and visual function in infants yield different estimates and may not accurately predict visual acuity and visual function in later life. Moreover, neither test-retest variability nor side-by-side comparisons of the various methods have been thoroughly evaluated in the same infant population. The purpose of this study was to provide such an evaluation. METHOD: The test-retest variability of visual acuity and visual function was evaluated for the Teller Acuity Card (TAC) procedure, sweep visual evoked potential (VEP), as well as latency and amplitude measured by transient pattern VEP. Groups of approximately 20 infants contributed test-retest data. Visual function estimated by the various methods in a larger group of infants (n = 118) was compared. Correlations between methods and the validity of the various methods to detect maturational changes between 4 and 8 months of age were also assessed. Administration of these tests was according to standard and usual procedures. RESULTS: The average percent difference between test and retest estimates of acuity as well as the SD was lowest for transient VEP latency (3%, 7% SD). The other methods were markedly more variable: sweep VEP (2%, 22% SD), TAC procedure (8%, 20% SD), and transient VEP amplitude (7.5%, 39% SD). Average coefficients of variation showed a similar trend: transient VEP latency, 8%; sweep VEP, 15%; TACs, 30%; and transient amplitude, 53%. Correlations among estimates by the methods were poor, but expected changes in visual maturation from 4 to 8 months of age were detected with all methods. CONCLUSIONS: All methods evaluated provide valid and reliable test-retest data for a group, but are less valid for estimating visual acuity and visual function of an individual subject. The poor correlations between any 2 of the testing methods suggest that each test assesses a different aspect of vision. Nonetheless, expected maturational changes between 4 and 8 months of age were readily detectable by all methods evaluated.

Aging↗

An imaging guide to the evaluation of third cranial nerve palsies.

PURPOSE: To devise a cost-effective imaging guide for the evaluation of third nerve palsies (TNP), based on an extensive review of the literature. METHODS: A review of the pertinent English language literature was performed to devise a guideline for the evaluation and neuroimaging of TNP. The authors also report a retrospective review of the cost of imaging studies performed on 91 patients with TNP. RESULTS: On the basis of the available literature, an imaging guide was developed and applied to a retrospective chart review of 91 patients from a single tertiary care center (Baylor College of Medicine). The cost effectiveness as well as the efficacy of the imaging guide was analyzed. CONCLUSIONS: The evaluation of TNP can be difficult; however, using such guides may allow for more appropriate and cost-effective evaluation of these patients.

Cost-Benefit Analysis↗

Accuracy of the Nidek ARK-900 objective refractor in comparison with retinoscopy in children ages 3 to 18 years.

PURPOSE: To compare the increased speed and accuracy of the Nidek ARK-900 objective refractor with standard retinoscopy. METHODS: In a prospective study, 100 children aged 3 to 18 years were refracted after cycloplegia. Visual acuity measurements were determined in randomized fashion with the Nidek objective refractor, by retinoscopy, and by subjective refraction. One eye from each patient was included in the study. RESULTS: Ninety-six percent of the children read the 20/30 line perfectly with the result from the objective refractor compared to 88% with retinoscopy. The mean +/- SD visual acuity value obtained with the objective refractor was 20/24 +/- 4.75 and with retinoscopy was 20/27 +/- 6.8, a significant difference (paired t value = 4.81, P < .001). CONCLUSION: The Nidek ARK-900, representing the third generation of objective refractors, is comparable or superior to retinoscopy in accuracy in children, can be easily run by an ophthalmic technician, and therefore eliminates the physician's examination time required for retinoscopy.

Adolescent↗

Evaluation of ocular safety: tirapazamine plus cisplatin in patients with metastatic melanomas.

Ninety-six patients with metastatic melanoma treated with two consecutive tirapazamine-cisplatin combination chemotherapy regimens were followed for signs of therapy-related ocular toxicity. Baseline and follow-up data were obtained such that each patient acted as his own control. A battery of vision-related tests was performed. These included: best corrected visual acuity, color vision, retinal fundus examination and electro-oculograms (EOG). A brief health-related quality of vision test was administered at each follow-up visit to detect and evaluate self-perceived changes in visual status. In the first study, 48 patients received i.v. tirapazamine over 2 h at 260 mg/m2 (group 1) while in the second study 48 patients (group 2) received i.v. tirapazamine at 390 mg/m2. Visual system assessment was conducted at three timepoints: first at baseline, then at 6 weeks post-baseline, i.e. after two courses of chemotherapy and visit two upon discontinuation of therapy. There was no difference in visual acuity between group 1 and group 2 at baseline, follow-up 1 or at follow-up 2. Grouped data indicate that visual acuity was not affected by either dosage of chemotherapy. Group 1 at baseline found 15% below the normal EOG cutoff point, increasing to 23% at follow-up 1 and increasing at follow-up visit 2 to 33%. Group 2 demonstrated the same EOG findings, but the results were more magnified: baseline, 24%; follow-up 1, 44%; and follow-up 2, 44%. After eliminating those with abnormal color vision baselines, 21% (nine of 42) group 1 patients demonstrated abnormal color vision total error scores at follow-up 1 and 16.7% (four of 24) at follow-up 2. Few individuals showed changes in the higher dosage group. With the exception of one person in each dosage group, all changes were along the blue-yellow (tritan) axis, which is associated with acquired color defects. Of 96 patients examined, proven fundus changes were found in only four subjects. These fundus findings included retinal hemorrhages, retinal nerve fiber layer infarcts (cotton wool spots) and small retinal pigment epithelium detachments. There was no systematic statistical significant difference among the various measures of visual system outcome between groups or test times. Data from all tests for individual patients in both groups reveals a sporadic distribution of changes in visual system tests. If toxicity were pronounced, one would expect consistency in the findings and all or most of the assessment tests would be abnormal for a particular patient. However, patients who were abnormal on one measure of acuity were not necessarily abnormal on the other measures.

Adult↗

Effect of dietary linoleic/alpha-linolenic acid ratio on growth and visual function of term infants.

OBJECTIVES: To determine the effect of alpha-linolenic acid (ALA) intake (or the dietary linoleic acid [LA]/ALA ratio) on the growth and visual function of term infants. STUDY DESIGN: Normal term infants were assigned randomly and in masked fashion at birth to receive formulas with approximately 16% of total fatty acids as LA and 0.4%, 1.0%, 1.7%, or 3.2% of fatty acids as ALA (LA/ALA ratios of 44, 18.2, 9.7, and 4.8) for the first 4 months of life. The fatty acid pattern of plasma phospholipids was determined shortly after birth and at approximately 21, 60, and 120 days of age. Anthropometric data were obtained at the same times and also at approximately 240 days of age. Transient visual evoked responses (VERs) were measured at approximately 120 and 240 days of age. For comparisons, anthropometric and VER data also were obtained in infants who were exclusively breast-fed for the first 4 months of life. RESULTS: Infants who received the formula with 3.2% ALA (LA/ALA ratio, 4.8) had higher plasma concentrations of phospholipid docosahexaenoic acid (DHA) but lower concentrations of arachidonic acid at 21, 60, and 120 days of age. Mean weight of this group at 120 days of age was 760 gm less (p < 0.05) than the mean weight of the group that received the formula with 0.4% ALA (LA/ALA ratio, 44). Despite differences in plasma phospholipid DHA contents among groups, neither VER latency nor amplitude differed significantly among formula groups or between any formula group and age-matched, breast-fed infants. CONCLUSIONS: The highest versus the lowest ALA intake (or the lowest vs the highest LA/ALA ratio) resulted in higher plasma phospholipid DHA content from 21 to 120 days of age but was not associated with improved visual function as assessed by transient VER. Moreover, mean body weight of infants who received the highest versus lowest ALA intake was less at 120 days (p < 0.05). These data suggest that the lower LA/ALA ratios currently recommended for infant formulas should not be adopted until the effect of such ratios on growth are evaluated more completely.

Arachidonic Acids↗

Effect of mitomycin C on the optic nerve in rabbits.

AIM: To prevent scarring after surgical optic nerve sheath decompression, it has been suggested that treating the area of fenestration with mitomycin C (MMC) might be effective. An animal model was used to test whether this toxic substance may cause optic neuropathy. METHODS: The optic nerves of 15 rabbits were exposed to balanced salt solution (BSS) or mitomycin C (MMC) in a concentration of 0.2 or 0.5 mg/ml. The unoperated fellow eyes and the eyes that received BSS served as controls. Steady state visual evoked potentials (VEPs) at 40, 50, and 60 Hz were recorded before and 4 weeks after surgery. The nerves were examined by light and electron microscopy after 5 weeks. RESULTS: VEPs in all non-operated eyes and eyes treated with BSS before and 4 weeks after surgery demonstrated responses at all three stimulus frequencies tested. Eyes operated with MMC had extinguished responses for one, two, or all the different temporal frequencies after 4 weeks with marked reduction in VEP amplitude. Eyes operated with MMC at a concentration of 0.5 mg/ml had significantly more reduced VEP responses than those where MMC 0.2 mg/ml was used. On histopathological examination, special stains for myelin and axons showed normal axons and myelin. On electron microscopy, no distinct abnormalities were seen among nerves operated with MMC and controls. CONCLUSION: The data from this study suggest that in rabbits, the application of MMC to the optic nerve has a dose dependent toxic effect in the short term postsurgical follow up period. While a functional alteration could be demonstrated reproducibly by steady state VEPs, the extent was not obvious on histopathological examination of the nerves.

Animals↗

Acute zonal occult outer retinopathy.

Retinal photoreceptor dysfunction is an uncommon and often unrecognized cause of acute visual loss. Acute zonal occult outer retinopathy (AZOOR) has been reported to cause cone and rod dysfunction. Patients with AZOOR may present with normal visual acuity, normal fluorescein angiography, and a normal fundus examination despite severe loss of visual field. A healthy young white female presented with acute, unilateral loss of visual field and an afferent pupillary defect, but normal visual acuity, color vision, fundus examination, and fluorescein angiogram. A pattern visual evoked potential was normal, but an electroretinogram showed a unilateral peripheral photoreceptor dysfunction consistent with the diagnosis of AZOOR. Ophthalmologists should be aware of the diagnosis of AZOOR and should consider an ERG in the evaluation of any patient with unexplained visual field loss even in the presence of normal visual acuity, color vision, fluorescein angiography, or retinal examination.

Acute Disease↗

Clinical characteristics and long-term postoperative results of infantile esotropia.

We classified 103 patients (206 eyes) with infantile esotropia and an average of 8.7 years of postoperative follow-up into four outcome groups. Of 103 patients, 28 (27%) had subnormal binocular vision; 24 (23%) had microtropia; 43 (42%) had small-angle deviation (< 20 prism diopters); and eight (8%) had large-angle deviation. A chi 2 analysis showed a significant difference (chi 2 = 16.22, P = .005) in the distribution of amblyopia among these four outcome groups. Visual acuity of 20/30 or better was attained in 174 of the 206 eyes (84%). The eyes of all 28 patients in the subnormal binocular vision group remained aligned after an average of eight years. In contrast, the eyes of six of 30 patients (20%) in the microtropia group and 11 of 43 (26%) in the small-angle deviation group lost the stability of horizontal alignment. We found that the two variables of latent-manifest nystagmus and persistent amblyopia at the time of surgery lead to less satisfactory outcomes. In contrast, patients with smaller preoperative angle of deviation or surgery completed before 1 year of age demonstrated an increased incidence of optimal (subnormal binocular vision) or desirable (microtropia) results. We recommend performing surgery after amblyopia has been thoroughly treated, and, whenever possible, completing the surgical treatment by 1 year of age.

Analysis of Variance↗

The gold foil electrode in pattern electroretinography.

A recent study found that the gold foil electrode produces large pattern electroretinogram amplitudes, but the test-retest reliability was low. In a three-center study, we observed that 90% of 29 patients who were tested with gold foil electrodes used three times appeared to have markedly lower amplitudes than when tested with new electrodes during the same session. Across study centers, the mean of the new electrode recordings was 3.78 microV (standard deviation, 1.13 microV), versus 2.93 microV (1.29 microV) for used electrodes. This 0.85-microV reduction (22%) was statistically significant (F = 7.10 p = 0.01). Electrodes used three times demonstrated an average change in the coefficient of variation of 14% (standard deviation/mean = coefficient of variation; new, 1.13/3.78 = 30%; used, 1.29/2.93 = 44%). Two of the study sites (Houston/Indianapolis) conducted test-retest pattern electroretinograms on a total of 18 patients and found the mean evoked potential to be 3.55 microV with new electrodes and 2.82 microV with used electrodes. The coefficient of variation for the test-retest data was 30% and 47% for new and used electrodes, respectively. Light microscopy showed small cracks on the surface of the electrode, with the number and configuration of the cracks varying in each electrode. The presence of cracks is further complicated by their proximity to the tear film. These sources of variation can result in significantly different impedances. We propose that constant flexion, as a result of patient blinking, causes cracks in the thin gold surface of the electrode. Used electrodes will produce lower pattern electroretinogram amplitudes and poor test-retest reliability.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult↗

The pattern visual-evoked potential in former preterm infants with retinopathy of prematurity.

PURPOSE: Flash and pattern visual-evoked potentials (VEPs) were recorded in 89 former preterm infants (< or = 1500 g birth weight), in whom retinopathy of prematurity (ROP) developed that spontaneously regressed without macular detachment (stages 2-4a). METHODS: Linear and stepwise regression analyses were performed to determine the correlations between transient pattern-reversal P1 VEP latency (n = 154 eyes) at a mean of 7.2 years (median, 6.9 years) postnatal age using a check size nominally equivalent to 20/100 (30 minutes) and the following nine parameters: three immaturity parameters (gestational age at birth, birth weight, and ROP zone at 1 month postnatal age); one postnatal insults parameter (worst ROP stage); two structural outcome parameters (macular ectopia and vessel traction); one functional outcome parameter (visual acuity); and two methodological parameters (postnatal age at VEP testing and VEP amplitude). RESULTS: Linear regression analyses, with P1 VEP latency as a dependent variable, identified the worst ROP stage (r = +0.42; P < 0.0001), macular ectopia (r = +0.42; P < 0.0001), visual acuity (r = -0.40; P < 0.0001), and vessel traction (r = +0.35; P < 0.0001) as significant correlates. Stepwise regression analysis demonstrated that worst ROP stage and macular ectopia accounted for 18% and 4% of the cumulative variance, respectively. CONCLUSIONS: P1 VEP latency correlates with postnatal insults, structural outcome, and functional outcome parameters in former preterms in whom ROP developed that spontaneously regressed without macular detachment. A permanent arrest in the development of the macula and/or prolonged traction on the incompletely developed macula may alter VEPs.

Evoked Potentials, Visual↗

The effect of optical defocus on the pattern electroretinogram in normal subjects and patients with Alzheimer's disease.

The pattern electroretinogram, thought to originate from the spatially sensitive inner retinal layers, was recorded in 16 patients with Alzheimer's disease and 16 age- and gender-matched control subjects under the following two test conditions: (1) optical defocus or inattention, without laser pointer, and (2) optical focus or attention, with laser pointer. By correcting for optical defocus with the laser pointer, control subjects increased their pattern electroretinogram amplitudes by 8% from a mean value of 2.65 microV (standard deviation, 1.12) to 2.87 microV (standard deviation, 0.93), whereas patients with Alzheimer's disease had a 19% increase in pattern electroretinogram amplitude from 2.20 microV (standard deviation, 0.86) to 2.62 microV (standard deviation, 0.64). By controlling for optical defocus, the coefficient of variation (standard deviation/mean) was reduced by 10% (from 42% to 32%) in normal subjects and by 14% (from 39% to 25%) in patients with Alzheimer's disease. A two-way analysis of variance (ANOVA) did not show a significant difference in amplitudes between populations, which indicates that the pattern electroretinogram may not be valuable in establishing an early diagnosis of Alzheimer's disease. In a second study conducted in 20 young, healthy normal subjects, plus lenses were used to defocus the checkerboard stimuli, before recording the pattern electroretinogram. We found that the pattern electroretinogram was extremely sensitive to optical defocusing such that the response amplitude decreased by 13% at 20/25 visual acuity and 19% at 20/30. Reduction of pattern electroretinogram amplitude caused by change in visual acuity is an independent source of artifact.(ABSTRACT TRUNCATED AT 250 WORDS)

Accommodation, Ocular↗

Visual improvement as a function of time after lamellar keratoplasty for keratoconus.

Twenty-eight keratoconic patients with either contact-lens intolerance or marked corneal scarring over the visual axis underwent lamellar keratoplasty for visual rehabilitation. All 28 patients returned for follow-up at six months, 27 (98%) had follow-up at one year, and 23 (82%) at two years. The 23 patients with two-year follow-up showed progressive improvement of visual acuity over time. At six months, 11 of 23 patients (48%) had visual acuity of 20/30 or better. At one year, 17 of 23 (74%) had 20/30 or better, and at two years, 21 of 23 (91%) had 20/30 or better. The average postoperative keratometry measurement at two years was 43.5 diopters (S.D. = 2.5 diopters), which represented an average reduction of 13 diopters from preoperative keratometry. All patients who were less than 32 years old obtained visual acuity of 20/30 or better after two years and reached this level significantly (F = 6.75, P = .02) sooner than those more than 32 years old. These results compare favorably with previously reported visual results after penetrating keratoplasty.

Adolescent↗

Visual acuity correlates with severity of retinopathy of prematurity in untreated infants weighing 750 g or less at birth.

Visual acuity was assessed in 72 patients who weighed 750 g or less at birth, had intact visual pathways as confirmed with computed tomography or magnetic resonance imaging, and had at least one eye evaluated for cicatricial sequelae after active, untreated retinopathy of prematurity without macular detachment (stage 4a or better). Visual acuities were obtained for 137 untreated, sighted eyes. Severity parameters for retinopathy of prematurity (stage of retinopathy of prematurity, refraction [in spherical equivalents], macular ectopia [in disc diameters], and vessel traction [in 30 degrees sectors]) was were significant predictors of visual acuity (P less than .0001) based on results of linear regression and stepwise regression analyses; however, parameters of retinal immaturity (birth weight, gestational age, and zone of retinopathy of prematurity) were not significant predictors of visual acuity. Visual acuity of the study eyes was good (median, 20/30; geometric mean, 20/33.58), with no statistical differences between eyes evaluated on last examination with linear Allen figures and those evaluated with linear Snellen test types.

Child, Preschool↗